Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).

Commercial Interest

The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Presenters and Disclosures

John Christodouleas, MD, MPH - No Disclosures
 
Dr. Christodouleas is a radiation oncologist and a nationally recognized authority on the treatment of prostate and bladder cancers. His research interest is in the use of new diagnostic and therapeutic technologies and how these can be used to optimize cancer cure rates and decrease side effects of treatments. He is an active researcher of proton therapy and MR-guided radiation therapy.

Dr. Christodouleas has written extensively about ways to optimize cancer control and quality of life for patients with cancer and has published primary research, reviews and editorials in a variety of journals including The New England Journal of Medicine, Cancer, and The International Journal of Radiation Oncology*Biology*Physics. He has authored more than 20 book chapters on the care of cancer patients and is coeditor of one of the leading textbooks in radiation oncology.

He was the University of Pennsylvania’s primary investigator to the Proton Collaborative Group and quality co-chair of the National Radiation Oncology Group Adjuvant Radiation trial for bladder cancer and is presently co-primary investigator for the MOMENTUM Study, an international observational cohort study of MR-guided radiation therapy.

Dr. Christodouleas has a strong interest in creating better linkages between the radiotherapy and cancer registry community. Since 2015, he has served on the Commission on Cancer’s Radiation Oncology Working Group, which manages the radiation data items in the STORE Manual and the National Cancer Database.